XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statement of Redeemable Noncontrolling Interest and Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock, $1.00 par value
Capital in Excess of Par Value
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Items
Total Thermo Fisher Scientific Inc. Shareholders’ Equity
Noncontrolling Interests
Beginning Balance at Dec. 31, 2021 $ 122              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 9              
Other comprehensive income/(loss) (7)              
Contributions from (distributions to) noncontrolling interests (7)              
Ending Balance at Jul. 02, 2022 117              
Balance (in shares) at Dec. 31, 2021   439,000,000            
Beginning Balance at Dec. 31, 2021 40,855 $ 439 $ 16,174 $ 35,431 $ (8,922) $ (2,329) $ 40,793 $ 62
Treasury stock beginning balance (in shares) at Dec. 31, 2021         45,000,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under employees' and directors' stock plans (in shares)   1,000,000            
Issuance of shares under employees' and directors' stock plans 97 $ 1 138   $ (42)   97  
Stock-based compensation 155   155       155  
Purchases of company common stock (in shares)         3,000,000      
Purchases of company common stock (2,000)       $ (2,000)   (2,000)  
Dividends declared (236)     (236)     (236)  
Net income/(loss) 3,879     3,879     3,879  
Other comprehensive items (395)         (395) (395)  
Contributions from (distributions to) noncontrolling interests (1)             (1)
Balance (in shares) at Jul. 02, 2022   440,000,000            
Treasury stock ending balance (in shares) at Jul. 02, 2022         48,000,000      
Ending Balance at Jul. 02, 2022 42,354 $ 440 16,467 39,074 $ (10,964) (2,724) 42,293 61
Beginning Balance at Apr. 02, 2022 113              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 4              
Other comprehensive income/(loss) 4              
Contributions from (distributions to) noncontrolling interests (4)              
Ending Balance at Jul. 02, 2022 117              
Balance (in shares) at Apr. 02, 2022   440,000,000            
Beginning Balance at Apr. 02, 2022 41,018 $ 440 16,292 37,528 $ (10,961) (2,343) 40,956 62
Treasury stock beginning balance (in shares) at Apr. 02, 2022         48,000,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under employees' and directors' stock plans 95   98   $ (3)   95  
Stock-based compensation 77   77       77  
Dividends declared (118)     (118)     (118)  
Net income/(loss) 1,664     1,664     1,664  
Other comprehensive items (382)         (381) (381) (1)
Balance (in shares) at Jul. 02, 2022   440,000,000            
Treasury stock ending balance (in shares) at Jul. 02, 2022         48,000,000      
Ending Balance at Jul. 02, 2022 42,354 $ 440 16,467 39,074 $ (10,964) (2,724) 42,293 61
Beginning Balance at Dec. 31, 2022 116              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 8              
Other comprehensive income/(loss) (4)              
Contributions from (distributions to) noncontrolling interests (7)              
Ending Balance at Jul. 01, 2023 113              
Balance (in shares) at Dec. 31, 2022   441,000,000            
Beginning Balance at Dec. 31, 2022 $ 44,032 $ 441 16,743 41,910 $ (12,017) (3,099) 43,978 54
Treasury stock beginning balance (in shares) at Dec. 31, 2022 50,157,275       50,000,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under employees' and directors' stock plans (in shares)         0      
Issuance of shares under employees' and directors' stock plans $ 99   137   $ (38)   99  
Stock-based compensation 150   150       150  
Purchases of company common stock (in shares)         5,000,000      
Purchases of company common stock (3,000)       $ (3,000)   (3,000)  
Dividends declared (271)     (271)     (271)  
Net income/(loss) 2,646     2,650     2,650 (4)
Other comprehensive items 175         175 175  
Excise tax from stock repurchases $ (29)       $ (29)   (29)  
Balance (in shares) at Jul. 01, 2023   441,000,000            
Treasury stock ending balance (in shares) at Jul. 01, 2023 55,448,286       55,000,000      
Ending Balance at Jul. 01, 2023 $ 43,802 $ 441 17,030 44,289 $ (15,084) (2,924) 43,752 50
Beginning Balance at Apr. 01, 2023 123              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 4              
Other comprehensive income/(loss) (7)              
Contributions from (distributions to) noncontrolling interests (7)              
Ending Balance at Jul. 01, 2023 113              
Balance (in shares) at Apr. 01, 2023   441,000,000            
Beginning Balance at Apr. 01, 2023 42,310 $ 441 16,889 43,064 $ (15,083) (3,054) 42,257 53
Treasury stock beginning balance (in shares) at Apr. 01, 2023         55,000,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under employees' and directors' stock plans (in shares)         0      
Issuance of shares under employees' and directors' stock plans 65   67   $ (2)   65  
Stock-based compensation 74   74       74  
Dividends declared (136)     (136)     (136)  
Net income/(loss) 1,358     1,361     1,361 (3)
Other comprehensive items 130         130 130  
Excise tax from stock repurchases $ 1       $ 1   1  
Balance (in shares) at Jul. 01, 2023   441,000,000            
Treasury stock ending balance (in shares) at Jul. 01, 2023 55,448,286       55,000,000      
Ending Balance at Jul. 01, 2023 $ 43,802 $ 441 $ 17,030 $ 44,289 $ (15,084) $ (2,924) $ 43,752 $ 50